According to the World Stroke Organization, one-in-four people will suffer a stroke at some point in their life.

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...

Shares of Ekso Bionics Holdings ($EKSO) are rising in pre-market hours after it agreed to combine with Applied Digital’s ...

Generative Bionics introduced the AMD-powered GENE.01 humanoid robot at CES 2026, designed for safe, tactile interaction with humans in real-world settings.

BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $33 from $30 and keeps a Buy rating on the shares as the firm ...

In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...

The catalyst for Ekso's impressive stock performance was the news that Applied Digital is pursuing a separation of its cloud segment into a standalone entity. This announcement was made on a day when ...

Ekso Bionics stock rises after non-binding term sheet with Applied Digital to merge cloud computing units into ChronoScale ...

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

EKSO Bionics shares surged after Applied Digital agreed to spin off its cloud business and combine it with EKSO. Shares climbed 64% to $8.91 in after-hours trading Monday. Through the close, the stock ...

Advanced Bionics Corp., a medical device company controlled by Los Angeles businessman Alfred E. Mann, agreed Tuesday to be acquired by industry giant Boston Scientific Corp. Based in Valencia, ...